Cord Blood America, Inc. announced financial results for the third quarter ended September 30, 2017. For the three months ended September 30, 2017, total revenue was $0.75 million, a decrease of approximately $0.03 million or 3.5% from $0.78 million in third quarter 2016. Of the $0.03 million decrease, approximately $0.02 million was attributable to the reduction in storage and processing revenue from a previously terminated agreement with a third party. Recurring storage revenue for the third quarter 2017 was $0.67 million, a decrease of 2.4% from recurring storage revenue of $0.69 million for the third quarter 2016. Net income for the three months ended September 30, 2017 was $0.18 million compared to $0.14 million in third quarter 2016. EBITDA for the three months ended September 30, 2017 was $0.24 million, an increase of $0.05 million or 26.7% from $0.19 in third quarter 2016 despite the reduction in revenue as the company has reduced costs.